Despite the sector looking slightly overvalued overall, we still see stocks that offer attractive valuations across the different industries.
Varian Medical Systems Spotlights New Edge™ Radiosurgery Suite for Non-Invasive Surgical Procedures at 2015 ChinaMed Exhibition in Beijing
Varian Medical Systems to Expand Operations in Atlanta
Inside the U.S. Antitrust Probe of Google--Update
Research and Markets: Global Radiation Therapy Market Report: 2015 Edition
Research and Markets: China Vacuum Pump Industry Report 2015-2018
Varian Medical Systems' VAR third-quarter results were in line with our expectations, and we are leaving our fair value estimate unchanged. Overall, revenue increased 7%, and net orders rose 13%, bringing the company's backlog at quarter-end to $1.6 billion. Revenue for the oncology system segment ...
While the sector looks slightly overvalued overall, we still see several stocks that offer attractive valuations across the different industries.
Varian Medical's VAR third-quarter fiscal 2006 results fall right in line with the seasonal patterns we expected from our current near-term modeling assumptions. The oncology group notched 14% growth, and customer demand continues to reflect a shift toward Varian's next-generation IGRT technology, ...